LifeWatch AG

EQS-Adhoc: LifeWatch AG: LifeWatch to adjust 2015 figures for one-off legal decision; guidance for 2016 confirmed


EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Statement
LifeWatch AG: LifeWatch to adjust 2015 figures for one-off legal decision;
guidance for 2016 confirmed

23.03.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

--------------------------------------------------------------------------------
LifeWatch to adjust 2015 figures for one-off legal decision; guidance for 2016
confirmed

Zug/Switzerland, March 23, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market, announces a change to the 2015
unaudited figures announced on March 17, 2016. This change is a result of the
negative arbitration decision in the dispute with Highmark which was received
last week.

LifeWatch intends to vigorously oppose the arbitration decision including
lodging an appeal, however, based on US GAAP accounting rules, it is necessary
for LifeWatch to include the arbitration award in the 2015 financial statements.
Furthermore, since the award relates to revenue from the years 2009 and 2010, US
GAAP rules mean that the award amount must be deducted from revenue, whereas the
interest is included under financial expense. Any change to the award as a
result of the appeal or otherwise would therefore also positively impact the
revenue line in future. Below, please find a table showing the changes from the
results already communicated:

Key Figures for Fiscal Year 2015(in USD millions)restated vs. reported
(unaudited)

                         As restated post Highmark arbitration FFY 2015 FFY 2014

Revenues                 88.63                                 106.63   98.47

EBITDA / (LBITDA)        (3.62)                                14.37    5.95

EBIT / (LBIT)            (11.66)                               6.34     0.3

Financial and other, net (3.96)                                (0.52)   (0.49)

Taxes                    4.46                                  (3.41)   (2.54)

Net income / (loss)      (11.95)                               1.62     (2.73)

Current Liabilities      50.21                                 28.82    22.56

Total equity             25.77                                 39.33    36.88

Balance sheet total      79.32                                 71.50    68.98
 
LifeWatchs' core business is strong and this one-off award will not affect the
operative business, although there will clearly be a negative impact on
liquidity. The company therefore confirms its 2016 guidance that revenues will
continue to grow at above market growth rates and that the adjusted EBIT, EBITDA
and Net Income figures will show an improvement in comparison to the originally
reported 2015 numbers.

The annual report will be available on the company website at:
http://irlifewatch.com/websites/lifewatch_ir/English/4010/annual-reports.htmlfro
m March 24, 2016.


For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail:investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solutions' company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is
a leading developer and manufacturer of telemedicine products. For additional
information, please visitwww.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE
AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES
OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH
AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE
ISSUER.

End of ad hoc announcement

+++++
Additional features:

Document:http://n.eqs.com/c/fncls.ssp?u=KYSRNBGWKH
Document title: LifeWatch to adjust 2015 figures for one-off legal decision;
guidance for 2016 confirmed

--------------------------------------------------------------------------------
23.03.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive:
http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.
--------------------------------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300  Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX


End of News EQS Group News Service
--------------------------------------------------------------------------------
448007  23.03.2016 
 



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: